Taiwan FDA registration dcc7140e2ab1b6e9272981f6f305734e

Nofafer Human Antivaricella Zoster Virus Immunoglobulin M Enzyme Immunoassay Set

TW: 諾法鐵人類抗水痘帶狀皰疹病毒免疫球蛋白M酵素免疫分析套組

Taiwan·Risk Class 2·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Aug 11, 2006 – Aug 11, 2026Active

Registration details

Analysis ID: dcc7140e2ab1b6e9272981f6f305734e
Customs Code: DHA00601727603

Company information

Manufacturer: GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH
Manufacturer Country: Germany
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: Enzyme immunoassay was used to legally detect immunoglobulin M classified antibodies against human varicella zoster virus in human serum.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3900 Varicella Disease Poison Serum Trial
Import Information: import

Dates and status

Registration Date: Aug 11, 2006
Expiry Date: Aug 11, 2026

About this record

Access comprehensive regulatory information for Nofafer Human Antivaricella Zoster Virus Immunoglobulin M Enzyme Immunoassay Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dcc7140e2ab1b6e9272981f6f305734e and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.